This website uses cookies to enhance your experience and to help us improve the site. Please see our Privacy Statement for further information. If you continue without changing your settings, we will assume that you are happy to receive these cookies. You can change your cookie settings at any time. I accept / More info
For more information on which cookies we use then please refer to our Cookie Policy.
These awards recognize KWM’s leadership in the practice areas of Finance, Compliance, Dispute Resolution, and Intellectual Property, and KWM’s...
A cross-industry initiative on the future economy. We're addressing the rapid pace of change in our markets and the emerging challenges and...
Belt and Road Initiative China's Belt and Road Initiative has attracted global business and media attention as one of the largest and most ambitious...
Setting up the KWM International Center is a significant strategic deployment for the firm.
King & Wood Mallesons’ cross-border team, advised Luye Pharma Hong Kong Limited (“Luye Pharma”) on its transaction signed with AstraZeneca relating...
King & Wood Mallesons’ London-based dispute resolution team is strengthening its dispute resolution practice with the promotion of Wilson Antoon to Of Counsel, with effect from 17 September 2018....
The cross-border team advised UK-based Vaccitech, a spin-out company from the University of Oxford’s Jenner Institute, one of the oldest and most renowned vaccine research centres in the world
London-based corporate team led by partners Joseph Newitt and Mike Wang acted for Wendy Yu, of Hong-Kong based Yu Holdings, in its investment in fashion label, Cefinn.
King & Wood Mallesons London-based corporate team acted for SPARK Advisory Partners Limited and Peterhouse Capital Limited, Nominated Adviser (Nomad) and Broker respectively, to Kin Group Plc, on its...